Zhejiang Jolly Pharmaceutical Co.,LTD (300181.SZ)
CNY 16.1
(-0.19%)
CNY 16.1
(-0.19%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 288.46 Million | 318.59 Million | 251.79 Million | 279.69 Million | 128.94 Million | 78.28 Million |
| Net Income | 390.76 Million | 285.52 Million | 191.98 Million | 95.31 Million | 23.89 Million | 26.18 Million |
| Depreciation & Amortization | 64.92 Million | 60.5 Million | 57.17 Million | 53.85 Million | 48.33 Million | 42.49 Million |
| Deferred income taxes | -1.75 Million | -2.9 Million | -7.07 Million | 74.35 Million | -3.4 Million | 634.7 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -182.34 Million | -56.01 Million | -17.04 Million | 99.49 Million | 9.58 Million | -11.07 Million |
| Other non-cash items | 15.12 Million | 28.58 Million | 19.68 Million | 31.03 Million | 47.13 Million | 20.67 Million |
| Investing Cash Flow | -263.57 Million | -113.33 Million | -36.89 Million | -121.25 Million | 15.12 Million | -1.92 Million |
| Investments in PPE | -131.71 Million | -178.03 Million | -147.95 Million | -58.35 Million | -40.45 Million | -153.92 Million |
| Acquisitions | 2.43 Million | 5.86 Million | 103.76 Thousand | 4.08 Million | 4 Million | 2.84 Million |
| Investment purchases | -181 Million | -248.45 Million | -166.15 Million | -78.02 Million | -128.6 Million | -136.4 Million |
| Sales/Maturities of investments | 41.03 Million | 304.83 Million | 285.22 Million | 7.68 Million | 172.8 Million | 270.02 Million |
| Other Investing Activities | 5.67 Million | 2.44 Million | -8.11 Million | 3.36 Million | 7.38 Million | 15.52 Million |
| Financing Cash Flow | -159.32 Million | 643.09 Million | -242.94 Million | -53.07 Million | -226.52 Million | -25.25 Million |
| Debt repayment | -204.83 Million | -282 Million | -406.5 Million | -316 Million | -452.37 Million | -291 Million |
| Dividends payments | -210.41 Million | -121.72 Million | -60.86 Million | -12.17 Million | -48.68 Million | -32.5 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 5.76 Million | 1.07 Billion | 233.82 Million | 293.82 Million | 295.01 Million | 298.24 Million |
| Accounts receivables | -27.63 Million | -207.98 Million | -60.91 Million | 18.28 Million | -38.51 Million | -55.48 Million |
| Accounts payables | 27.63 Million | 216.4 Million | 127.09 Million | 19.68 Million | 24.62 Million | 30.45 Million |
| Inventory | -99.15 Million | -61.53 Million | -76.15 Million | -12.83 Million | 26.87 Million | 13.31 Million |
| Other working capital | -83.19 Million | -2.9 Million | -7.07 Million | 74.35 Million | -3.4 Million | -24.39 Million |
| Cash at beginning of period | 1.06 Billion | 214.22 Million | 242.27 Million | 136.9 Million | 219.36 Million | 168.26 Million |
| Cash at end of period | 928.14 Million | 1.06 Billion | 214.22 Million | 242.27 Million | 136.9 Million | 219.36 Million |
| Capital Expenditure | -131.71 Million | -178.03 Million | -147.95 Million | -58.35 Million | -40.45 Million | -153.92 Million |
| Effect of forex changes on cash | 114.25 | -154.00 | 0.89 | - | - | -1933.29 |
| Net cash flow / Change in cash | -134.43 Million | 848.35 Million | -28.04 Million | 105.36 Million | -82.45 Million | 51.1 Million |
| Free Cash Flow | 156.74 Million | 140.55 Million | 103.84 Million | 221.33 Million | 88.48 Million | -75.63 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 125.42 Million | 153.63 Million | 142.41 Million | 96.07 Million | 390.76 Million | 89.2 Million |
| Depreciation & Amortization | - | 18.04 Million | 18.04 Million | 64.03 Million | 64.92 Million | -31.35 Million |
| Deferred income taxes | - | - | - | - | -1.75 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -416 Million | - | -126.78 Million | -182.34 Million | 138.02 Million |
| Other non-cash items | -126.64 Million | 62.68 Million | -125.34 Million | 31.19 Million | 15.12 Million | -95.08 Million |
| Investing Cash Flow | -57.79 Million | -19.94 Million | 74.16 Million | -148.42 Million | -263.57 Million | -22.18 Million |
| Investments in PPE | -57.99 Million | -21.24 Million | -76.49 Million | -6.53 Million | -131.71 Million | -31.21 Million |
| Acquisitions | 198.2 Thousand | 302 Thousand | 20 Thousand | 2.42 Million | 2.43 Million | 5799.00 |
| Investment purchases | - | - | -19.99 Thousand | -150 Million | -181 Million | -5799.00 |
| Sales/Maturities of investments | - | 1 Million | 150.63 Million | 5204.51 | 41.03 Million | 9.02 Million |
| Other Investing Activities | 198.2 Thousand | 1.3 Million | 19.99 Thousand | 5.67 Million | 5.67 Million | 5799.08 |
| Financing Cash Flow | -60.72 Million | -272.47 Million | -22.64 Million | 11.35 Million | -159.32 Million | -23.59 Million |
| Debt repayment | -128.61 Million | -57.69 Million | -89.4 Million | -3.95 Million | -204.83 Million | -76.83 Million |
| Dividends payments | -5.69 Million | -312.57 Million | -1.15 Million | -210.41 Million | -210.41 Million | -6.75 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -195.03 Million | -328.13 Million | -1.48 Million | 11.91 Million | 5.76 Million | 59.99 Million |
| Accounts receivables | - | -328.17 Million | - | -27.63 Million | -27.63 Million | 59.15 Million |
| Accounts payables | - | - | - | - | 27.63 Million | - |
| Inventory | - | -87.82 Million | - | -99.15 Million | -99.15 Million | 78.87 Million |
| Other working capital | - | - | - | - | -83.19 Million | - |
| Cash at beginning of period | 902.59 Million | 1.01 Billion | 928.49 Million | 1 Billion | 1.06 Billion | 945.71 Million |
| Cash at end of period | 783.19 Million | 925.91 Million | 997.07 Million | 928.14 Million | 928.14 Million | 1 Billion |
| Capital Expenditure | -57.99 Million | -21.24 Million | -76.49 Million | -6.53 Million | -131.71 Million | -31.21 Million |
| Effect of forex changes on cash | -87.46 | 46.83 | 9.10 | -108.40 | 114.25 | -37.35 |
| Net cash flow / Change in cash | -119.39 Million | -86.11 Million | 68.58 Million | -72.55 Million | -134.43 Million | 54.98 Million |
| Free Cash Flow | -59.21 Million | 177.03 Million | -59.42 Million | 57.97 Million | 156.74 Million | 69.57 Million |
HDRPF
0HIN
ELM
FDY
MAHLIFE
KYP